載入錯誤
看來載入頁面時發生了錯誤.
重新載入
我們的團隊已收到通知,但若此問題持續,請透過
電郵支援widget工具
聯絡我們。
HK
前往
快閃促銷
登入
觀察名單
觀點
ProPicks AI
篩選器
數據瀏覽
圖表
已儲存工作
收起
Dyne Therapeutics Inc
NASDAQGS:DYN
美國 / 保健 / 生物科技
加入觀察名單
貨幣
$
綜觀
股息
財報
模型
財務狀況
比較
穩健度
圖表
市盈率倍數
股價
7.85
USD
公允價值
8.42
USD
Metrics
Range
Conclusion
Selected LTM P/E Multiple
-3.1x - -3.4x
-3.3x
Selected Fwd P/E Multiple
-1.8x - -2.0x
-1.9x
Fair Value
$8 - $8.84
$8.42
Upside
7.1% - 18.4%
12.8%
Benchmarks
-
Full Ticker
Solid Biosciences Inc.
-
NasdaqGS:SLDB
PepGen Inc.
-
NasdaqGS:PEPG
Moderna, Inc.
-
NasdaqGS:MRNA
Alnylam Pharmaceuticals, Inc.
-
NasdaqGS:ALNY
Sarepta Therapeutics, Inc.
-
NasdaqGS:SRPT
Dyne Therapeutics, Inc.
-
NasdaqGS:DYN
-
-
-
Multiples Valuation: Price / EPS
分享
儲存
股價
7.85
USD
公允價值
8.42
USD
看漲
12.8%
Price / LTM EPS Multiple
Price / Fwd EPS Multiple
Fair Value
Benchmark Editor
Select Price / LTM EPS Ratio
Benchmark Companies
SLDB
PEPG
MRNA
ALNY
SRPT
DYN
NasdaqGS:SLDB
NasdaqGS:PEPG
NasdaqGS:MRNA
NasdaqGS:ALNY
NasdaqGS:SRPT
NasdaqGS:DYN
Historical Net Income Growth
5Y CAGR
NM-
NM-
NM-
NM-
NM-
NM-
3Y CAGR
NM-
NM-
NM-
NM-
NM-
NM-
Latest Twelve Months
-29.9%
-14.4%
24.5%
36.8%
143.9%
-34.5%
Historical Net Income Profit Margin
5 Year Average Margin
-1033.9%
NA
-89.6%
-108.6%
-70.8%
NA
Prior Fiscal Year
NA
NA
-68.8%
-24.1%
-43.1%
NA
Latest Fiscal Year
NA
NA
-110.0%
-12.4%
12.4%
NA
Latest Twelve Months
NA
NA
-110.0%
-12.4%
12.4%
NA
Current Trading Multiples
EV / LTM EBITDA
-0.7x
0.7x
-0.4x
-259.1x
20.1x
-0.7x
Price / LTM Sales
NA
NA
3.2x
13.8x
2.8x
NA
LTM P/E Ratio
-1.7x
-0.4x
-2.9x
-111.8x
22.5x
-2.7x
Low
Mid
High
Benchmark LTM P/E Ratio
-111.8x
-1.7x
22.5x
Historical LTM P/E Ratio
-26.4x
-3.9x
-2.7x
Selected P/E Multiple
-3.1x
-3.3x
-3.4x
(x) LTM Net Income
(317)
(317)
(317)
(=) Equity Value
987
1,039
1,091
(/) Shares Outstanding
113.1
113.1
113.1
Implied Value Range
8.73
9.19
9.65
FX Rate: USD/USD
1.0
1.0
1.0
Market Price
Implied Value Range (Trading Cur)
8.73
9.19
9.65
7.47
Upside / (Downside)
16.8%
23.0%
29.1%
支援算式
Equity Waterfall
Financials
Historical Multiples
Equity Value
Benchmark Companies
(in millions)
SLDB
PEPG
MRNA
ALNY
SRPT
DYN
Value of Common Equity
210
36
10,361
31,071
5,301
845
(/) Shares Outstanding
77.5
32.7
386.6
129.5
97.0
113.1
Implied Stock Price
2.71
1.10
26.80
240.01
54.63
7.47
FX Conversion Rate to Trading Currency
1.00
1.00
1.00
1.00
1.00
1.00
Implied Stock Price (Trading Cur)
2.71
1.10
26.80
240.01
54.63
7.47
Trading Currency
USD
USD
USD
USD
USD
USD
FX Rate to Reporting Currency
1.00
1.00
1.00
1.00
1.00
1.00
版權所有。
使用條款
繁體中文
English (UK)
English (India)
English (Canada)
English (Australia)
English (South Africa)
English (Philippines)
Deutsch
Español (España)
Español (México)
Français
Italiano
Nederlands
Português (Portugal)
Polski
Português (Brasil)
Русский
Türkçe
Ελληνικά
Svenska
Suomi
日本語
한국어
简体中文
Bahasa Indonesia
Bahasa Melayu
ไทย
Tiếng Việt
हिंदी